Faculty, Staff and Student Publications

Language

English

Publication Date

6-1-2022

Journal

Journal of the American Academy of Dermatology

DOI

35122894

PMID

35122894

PMCID

PMC8808428

PubMedCentral® Posted Date

2-2-2022

PubMedCentral® Full Text Version

Post-print

Abstract

Although the COVID-19 pandemic has been the defining global health crisis of our time, public health officials have been sounding the alarm of another ominous threat for years: an impending antimicrobial resistance crisis. In dermatology, antibiotics are often used for prolonged courses in the treatment of skin and soft tissue infections and common inflammatory skin conditions, increasing the risk of microbiome alteration and antibiotic-related adverse effects, all while exerting consequential selective pressures on both pathogenic and bystander bacteria. In this review, we hope to raise awareness of the crisis of antimicrobial resistance and review resistance concerns related to dermatology-relevant bacterial pathogens.

Keywords

Anti-Bacterial Agents, Bacteria, COVID-19, Drug Resistance, Bacterial, Humans, Methicillin-Resistant Staphylococcus aureus, Microbial Sensitivity Tests, Pandemics, antibiotic resistance, antimicrobial resistance, bacteria, clindamycin-resistant Streptococcus pyogenes, dermatology, drug-resistant Mycobacterium tuberculosis, methicillin-resistant Staphylococcus aureus, multidrug-resistant Pseudomonas aeruginosa, resistant Cutibacterium acnes

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.